The government has committed to working with the organisation to establish “a sustainable funding and operating model” for the future, according to CPE chief executive Janet Morrison.
In an interview with Pharmacy Business, Malcolm Harrison explains how issues with medicine shortages are having a detrimental impact on patient care...
Uniphar’s 2024 profits were predominantly driven by organic growth, with Pharma and Medtech divisions delivering organic growth of 17.6% and 9.1% respectively
